REQUEST A DEMO
Total
USD $0.00
Search more companies

Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hainan Huluwa Pharmaceutical Group Co., Ltd. Profile Updated: March 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) is an enterprise based in China. Its main office is in Haikou. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on June 22, 2005. There are currently 2,083 (2022) people employed by Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司). In its most recent financial highlights, the company reported a net sales revenue drop of 33.88% in Q3C2025. There was a total negative growth of 9.93% in Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司)’s total assets over the same period. The net profit margin of Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) increased by 9.87% in 2025.

Headquarters
No. 30, Anyu 1st Road, Xiuying District, Haikou City, Hainan Province
Haikou; Hainan; Postal Code: 570311

Contact Details: Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report to view the information.

Website: http://www.huluwayaoye.com

Basic Information
Total Employees:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report to view the information.
Registered Capital:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report to view the information.
Incorporation Date:
June 22, 2005
Key Executives
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
41.76%
Purchase this report to view the information.
14.38%
Purchase this report to view the information.
8.21%
Purchase this report to view the information.
4.89%
Purchase this report to view the information.
4.7%
Subsidiaries
Chengde Xin Aimin Pharmaceutical Co., Ltd.
100%
Guangxi Laibin Huluwa Pharmaceutical Co., Ltd.
100%
Guangxi Weiwei Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hainan Huluwa Pharmaceutical Group Co., Ltd. (海南葫芦娃药业集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-33.88%
Total Operating Revenue
-34.85%
Operating Profit
97.14%
Net Profit/Loss for the Period
93.34%
Total Assets
-9.93%
Total Equity
-38.52%
Operating Profit Margin
10.27%
Net Profit Margin
9.87%
Return on Equity (ROE)
8.44%
Debt / Equity
53411%
Quick Ratio
-200.71%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?